查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1319972

藥物研發技術市場：按技術、藥物類型、最終用戶分類 - 全球預測 2023-2030

Drug Discovery Technologies Market by Technology, Drug Type, End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球藥物研發技術市場預計將大幅成長，年複合成長率為10.61%，預計2023年將達到645.7億美元，2030年將達到1,318.8億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球藥物研發技術市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對整體收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解自家公司在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.藥物研發技術的全球市場規模與預測為何？

2. 在預測期內，COVID-19 對全球藥物研發技術市場的阻礙因素和影響為何？

3. 在預測期內，全球藥物研發技術市場需要投資哪些產品/細分市場/用途/領域？

4.你們在全球藥物研發技術市場的競爭策略是什麼？

5.全球藥物研發技術市場的技術趨勢和法律規範是什麼？

6.全球藥物研發技術市場主要供應商的市佔率為何？

7. 您認為藥物研發技術進入全球市場的合適型態和策略性舉措是什麼？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 增加使用小分子藥物和生物製劑來治療慢性疾病和感染疾病
      • 政府對藥物研發發現和開發的支持性配合措施和投資
      • 世界各地 CDMO 快速採用藥物研發技術
    • 抑制因素
      • 藥物研發和開發的初始設定成本較高
    • 機會
      • 藥物研發平台的持續技術進步
      • 開發新藥物分子的研發成本增加
    • 任務
      • 嚴格的法規環境和熟練專業人員的有限性
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 技術市場：依技術分類

  • 介紹
  • 生物分析設備
  • 生物晶片
  • 生物資訊學
  • 組合化學
  • 基因組學
  • 高通量篩選
  • 奈米科技
  • 藥物基因組學
  • RNA干擾

第7章 技術市場：依藥物類型

  • 介紹
  • 生物製品
  • 小分子藥物

第8章 技術市場：依最終用戶分類

  • 介紹
  • 生物製藥公司
  • 生技公司
  • 製藥公司
  • 研究機構

第9章 北美和南美藥物研發技術市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太藥物研發技術市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲藥物研發技術市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業
    • 併購
    • 合約、合作和夥伴關係
    • 新產品發布和功能增強
    • 投資、資金籌措
    • 獎項/獎勵/擴展

第13章上市公司名單

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-4348D129FA8C

The Global Drug Discovery Technologies Market is forecasted to grow significantly, with a projected USD 64.57 billion in 2023 at a CAGR of 10.61% and expected to reach a staggering USD 131.08 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Drug Discovery Technologies Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Drug Discovery Technologies Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Technology, market is studied across Bioanalytical Instruments, Biochips, Bioinformatics, Combinatorial Chemistry, Genomics, High Throughput Screening, Nanotechnology, Pharmacogenomics, and RNA interference. The Biochips commanded largest market share of 17.31% in 2022, followed by Nanotechnology.

Based on Drug Type, market is studied across Biologic Drugs and Small-molecule Drugs. The Small-molecule Drugs commanded largest market share of 76.36% in 2022, followed by Biologic Drugs.

Based on End User, market is studied across Biopharmaceutical Companies, Biotech Companies, Pharmaceutical Companies, and Research Institutes. The Pharmaceutical Companies commanded largest market share of 40.76% in 2022, followed by Biopharmaceutical Companies.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 41.64% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Drug Discovery Technologies Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Drug Discovery Technologies Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Drug Discovery Technologies Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Drug Discovery Technologies Market?

4. What is the competitive strategic window for opportunities in the Global Drug Discovery Technologies Market?

5. What are the technology trends and regulatory frameworks in the Global Drug Discovery Technologies Market?

6. What is the market share of the leading vendors in the Global Drug Discovery Technologies Market?

7. What modes and strategic moves are considered suitable for entering the Global Drug Discovery Technologies Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Drug Discovery Technologies Market, by Technology, 2022 vs 2030
  • 4.3. Drug Discovery Technologies Market, by Drug Type, 2022 vs 2030
  • 4.4. Drug Discovery Technologies Market, by End User, 2022 vs 2030
  • 4.5. Drug Discovery Technologies Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing use of small-molecular and biologics drugs to treat chronic and infectious disorders
      • 5.1.1.2. Supportive government iniatives and investments for drug discovery and development
      • 5.1.1.3. Rapid adoption of drug discovery technologies by CDMOs worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High initial setup cost for drug discovery and development
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing technological advancements in drug discovery platforms
      • 5.1.3.2. Increasing research and development expenditure for development of novel drug molecules
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory environment and limited availability of skilled professionals
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Drug Discovery Technologies Market, by Technology

  • 6.1. Introduction
  • 6.2. Bioanalytical Instruments
  • 6.3. Biochips
  • 6.4. Bioinformatics
  • 6.5. Combinatorial Chemistry
  • 6.6. Genomics
  • 6.7. High Throughput Screening
  • 6.8. Nanotechnology
  • 6.9. Pharmacogenomics
  • 6.10. RNA interference

7. Drug Discovery Technologies Market, by Drug Type

  • 7.1. Introduction
  • 7.2. Biologic Drugs
  • 7.3. Small-molecule Drugs

8. Drug Discovery Technologies Market, by End User

  • 8.1. Introduction
  • 8.2. Biopharmaceutical Companies
  • 8.3. Biotech Companies
  • 8.4. Pharmaceutical Companies
  • 8.5. Research Institutes

9. Americas Drug Discovery Technologies Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Drug Discovery Technologies Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Drug Discovery Technologies Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player
    • 12.3.1. Merger & Acquisition
      • 12.3.1.1. Drug Development Technology player ArisGlobal Completes Acquisition of Amplexor Life Sciences.
      • 12.3.1.2. Charles River Secures USD 50 Million Acquisition of Drug Discovery Tech Company.
      • 12.3.1.3. BioNTech to Acquire Ai Drug Discovery Start-Up Instadeep for £362m (USD 440.15 Million)
    • 12.3.2. Agreement, Collaboration, & Partnership
      • 12.3.2.1. Luxna Announces Collaboration Agreement for Drug Discovery Research with Servier
      • 12.3.2.2. Japanese Startup Veritas In Silico Inks New Partnership For Mrna-Targeted Small Molecule Drug Discovery
      • 12.3.2.3. CytoReason Announces Expanded Collaboration Deal with Pfizer to Deliver AI for Drug Discovery and Development
      • 12.3.2.4. Aurigene Discovery Technologies Limited Announces Drug Discovery, Development and Commercialization Partnership with EQRx
    • 12.3.3. New Product Launch & Enhancement
      • 12.3.3.1. CHARM Launches AI Drug Discovery Technology With USD 50 Million Series A Financing
    • 12.3.4. Investment & Funding
      • 12.3.4.1. Iktos Raises €15.5M (USD 16.34 million) to Expand AI Drug Discovery Technologies
    • 12.3.5. Award, Recognition, & Expansion
      • 12.3.5.1. Ablexis and AlivaMab Discovery Services Announce Expansion of Antibody Drug Discovery and Engineering Capabilities

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. DRUG DISCOVERY TECHNOLOGIES MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2022 VS 2030
  • FIGURE 3. DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
  • FIGURE 5. DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2022 VS 2030 (%)
  • FIGURE 6. DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2022 VS 2030 (%)
  • FIGURE 7. DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. DRUG DISCOVERY TECHNOLOGIES MARKET DYNAMICS
  • FIGURE 9. DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. DRUG DISCOVERY TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. DRUG DISCOVERY TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. DRUG DISCOVERY TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 5. DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOANALYTICAL INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOCHIPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COMBINATORIAL CHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY NANOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY RNA INTERFERENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY SMALL-MOLECULE DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 18. DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM DRUG DISCOVERY TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. DRUG DISCOVERY TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 150. DRUG DISCOVERY TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 151. DRUG DISCOVERY TECHNOLOGIES MARKET LICENSE & PRICING